These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3872057)

  • 21. Comparative electrophysiologic effects of bepridil, verapamil and diltiazem in conscious and anesthetized dogs.
    Kantelip JP; Alatienne M; Talmant JM; Ghyselinck N; Duchêne-Marullaz P
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):5-18. PubMed ID: 3493741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of calcium channel blockers on sinoatrial conduction in the isolated and blood-perfused dog atrium.
    Kobayashi M; Shimotori M; Ogiwara Y; Chiba S
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):72-82. PubMed ID: 3485962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-angina effect of the calcium antagonist bepridil in stable angina pectoris].
    Schneider W; Mehlhorn C; Kaltenbach M; Bussmann WD
    Z Kardiol; 1985 Jun; 74(6):341-7. PubMed ID: 3895761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical pharmacology of calcium antagonists].
    Lauterburg BH
    Schweiz Med Wochenschr; 1987 Mar; 117(13):496-501. PubMed ID: 3576161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of diltiazem and other calcium entry blockers.
    Hermann P; Morselli PL
    Acta Pharmacol Toxicol (Copenh); 1985; 57 Suppl 2():10-20. PubMed ID: 3904330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bepridil, myocardial accumulation kinetics and dynamic effects in the isolated rabbit heart.
    Nielsen-Kudsk F; Askholt J; Jakobsen P
    Pharmacol Toxicol; 1988 Aug; 63(2):122-8. PubMed ID: 3263633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of calcium-entry blockers.
    McAllister RG; Hamann SR; Blouin RA
    Am J Cardiol; 1985 Jan; 55(3):30B-40B. PubMed ID: 3881917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oral administration of a new calcium channel blocking agent, bepridil on antipyrine clearance in man.
    Funck-Brentano C; Chaffin PL; Wilkinson GR; McAllister B; Woosley RL
    Br J Clin Pharmacol; 1987 Oct; 24(4):559-60. PubMed ID: 3500736
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical pharmacokinetics of calcium channel antagonists.
    McAllister RG
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S340-5. PubMed ID: 6184565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bepridil: a new long-acting calcium channel blocking agent.
    Zeller FP; Spinler SA
    Drug Intell Clin Pharm; 1987 Jun; 21(6):487-92. PubMed ID: 3301244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of PN 200-110 (isradipine), a new calcium antagonist, after oral administration in man.
    Tse FL; Jaffe JM
    Eur J Clin Pharmacol; 1987; 32(4):361-5. PubMed ID: 2956112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of bepridil on calcium release from rat heart mitochondria.
    Schneider JM; Berson G; Cruz C; Younes A
    Pharmacol Res Commun; 1988 Mar; 20(3):183-94. PubMed ID: 3260385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative electrophysiologic profiles of calcium antagonists with particular reference to bepridil.
    Singh BN; Nademanee K; Feld G; Piontek M; Schwab M
    Am J Cardiol; 1985 Mar; 55(7):14C-19C. PubMed ID: 3872052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
    Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacokinetics of amiodarone.
    Latini R; Tognoni G; Kates RE
    Clin Pharmacokinet; 1984; 9(2):136-56. PubMed ID: 6370540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist.
    Abernethy DR
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S4-7. PubMed ID: 16296697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
    Agre P; Virshup D; Bennett V
    J Clin Invest; 1984 Sep; 74(3):812-20. PubMed ID: 6088585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacokinetics of amlodipine.
    Meredith PA; Elliott HL
    Clin Pharmacokinet; 1992 Jan; 22(1):22-31. PubMed ID: 1532771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacokinetics of prazosin.
    Jaillon P
    Clin Pharmacokinet; 1980; 5(4):365-76. PubMed ID: 6994981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of five different organic calcium antagonists on guinea-pig isolated trachea.
    Advenier C; Cerrina J; Duroux P; Floch A; Renier A
    Br J Pharmacol; 1984 Jul; 82(3):727-33. PubMed ID: 6611187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.